Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2–Tie2 complex
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
The Tie receptor tyrosine kinases and their angiopoietin (Ang) ligands play central roles in developmental and tumor-induced angiogenesis. Here we present the crystal structures of the Tie2 ligand-binding region alone and in complex with Ang2. In contrast to prediction, Tie2 contains not two but three immunoglobulin (Ig) domains, which fold together with the three epidermal growth factor domains into a compact, arrowhead-shaped structure. Ang2 binds at the tip of the arrowhead utilizing a lock-and-key mode of ligand recognition-unique for a receptor kinase-where two complementary surfaces interact with each other with no domain rearrangements and little conformational change in either molecule. Ang2-Tie2 recognition is similar to antibody-protein antigen recognition, including the location of the ligand-binding site within the Ig fold. Analysis of the structures and structure-based mutagenesis provide insight into the mechanism of receptor activation and support the hypothesis that all angiopoietins interact with Tie2 in a structurally similar manner.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, the previously identified TIE2 binding site in ANGPT2 FLD (16) is accessible in our ANGPT2147–496–α5Calf1-2 SAXS model.”
From Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling (2026) · cites this paper as [16]
In the citing paper
“Interestingly, the model of the dimeric ANGPT2147–496 in complex with the inactive, half-bent α5β1-integrin and TIE2 ECDs could be created without steric clashes while maintaining the overall geometry and interactions of the existing structures found in this study and previously (13, 16, 54–56) (Figure 8, A and B, and Supplemental Video 2).”
From Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling (2026) · cites this paper as [16]
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715 · cited 1×
“and refinement proceeded with molecular dynamics and energy minimization in CN”
BackgroundJones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070 · cited 1×
“This arises as a result of two distinct processes termed vasculogenesis (formation of major primitive blood vessels) and angiogenesis (remodeling and extension of the adult vasculature”
BackgroundVascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699 · cited 1×
“dtd" [ ]> The development of the adult cardiovascular system involves the differentiation of endothelial cells from precursor angioblasts and their subsequent migration, growth and sproutin”
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81812-7 · Cited by 1,989
Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains
Ogiso, H., Ishitani, R., Nureki, O., Fukai, S., Yamanaka, M., Kim, J.-H., Saito, K., Sakamoto, A., Inoue, M., Shirouzu, M., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00963-7 · Cited by 1,227 · cited 1×
“or from ligand-induced conformational changes in the receptor that result in its dimerization (as in EGF”
BackgroundBlood Vessel Formation: What Is Its Molecular Basis?
Folkman, J., & D'Amore, P. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81810-3 · Cited by 1,215 · cited 1×
“dtd" [ ]> The development of the adult cardiovascular system involves the differentiation of endothelial cells from precursor angioblasts and their subsequent migration, growth and sproutin”
Protein Tyrosine Kinase Structure and Function
Hubbard, S. R., & Till, J. H. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.373 · Cited by 1,171
Gale, N. W., Thurston, G., Hackett, S. F., Renard, R., Wang, Q., McClain, J., Martin, C., Witte, C., Witte, M. H., Jackson, D., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00217-4 · Cited by 1,018 · cited 1×
“These studies have shown that the differential angiopoietin activities are controlled at the level of the target cell, differing, for example, in blood-vessel endothelial cells and lymphatic endothelial cell”
BackgroundAngiogenesis and Tumor Metastasis
Zetter, B. R. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.407 · Cited by 1,015
Garrett, T. P. J., McKern, N. M., Lou, M., Elleman, T. C., Adams, T. E., Lovrecz, G. O., Zhu, H.-J., Walker, F., Frenkel, M. J., Hoyne, P. A., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00940-6 · Cited by 783
Crystal Structure at 1.7 Å Resolution of VEGF in Complex with Domain 2 of the Flt-1 Receptor
Wiesmann, C., Fuh, G., Christinger, H. W., Eigenbrot, C., Wells, J. A., & de Vos, A. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80456-0 · Cited by 486 · cited 1×
“Ligand-induced dimerization may result either from direct binding of a single ligand molecule (or a preformed ligand dimer) to two different receptors (as in vascular endothelial growth factor”
BackgroundStratmann, A., Risau, W., & Plate, K. H. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65733-1 · Cited by 485 · cited 1×
“Tie2 overexpression has been documented in breast, ovarian and hepatocellular tumors, as well as in glioblastoma”
BackgroundAngiopoietins 3 and 4: Diverging gene counterparts in mice and humans
Valenzuela, D. M., Griffiths, J. A., Rojas, J., Aldrich, T. H., Jones, P. F., Zhou, H., McClain, J., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.1904 · Cited by 472
Harpaz, Y., & Chothia, C. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1312 · Cited by 432 · cited 1×
“Immunoglobulin domains are commonly classified into V, C1, C2 and I set”
BackgroundStein, E., Lane, A. A., Cerretti, D. P., Schoecklmann, H. O., Schroff, A. D., Van Etten, R. L., & Daniel, T. O. (1998) · Genes & Development · doi:10.1101/gad.12.5.667 · Cited by 424 · cited 1×
“A similar behavior has been reported for members of the Eph receptor kinase family, where different biological responses have been attributed to different oligomerization states of the activating ligan”
BackgroundTie receptors: new modulators of angiogenic and lymphangiogenic responses
Jones, N., Iljin, K., Dumont, D. J., & Alitalo, K. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35067005 · Cited by 418
Dumont, D., Yamaguchi, T. P., Conlon, R. A., Rossant, J., & Breitman, M. L. (1992) · PubMed · Cited by 410
The design and implementation of SnB version 2.0
Weeks, C. M., & Miller, R. (1999) · Journal of Applied Crystallography · doi:10.1107/s0021889898010504 · Cited by 388
Angiogenesis Ischemic and Neoplastic Disorders
Semenza, G. L. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152418 · Cited by 386 · cited 1×
“Angiogenesis also occurs during solid tumor growth and development, resulting in an enriched nutrient and oxygen suppl”
BackgroundAntiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2
Lin, P., Buxton, J. A., Acheson, A., Radziejewski, C., Maisonpierre, P. C., Yancopoulos, G. D., Channon, K. M., Hale, L. P., Dewhirst, M. W., George, S. E., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8829 · Cited by 371 · cited 1×
“Administration of soluble Tie2 ectodomain reduces vascular length density and tumor growth in vivo”
BackgroundDirect Cell Adhesion to the Angiopoietins Mediated by Integrins
Carlson, T. R., Feng, Y., Maisonpierre, P. C., Mrksich, M., & Morla, A. O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100282200 · Cited by 268 · cited 1×
“Ang1, for example, binds α 5 β 1 integrin with a similar affinity as Tie2, suggesting that there is an alternative Ang1-specific receptor whose activation results in a variety of cellular responses, including cell adhesion and activation of MAP kinase”
BackgroundMolecular recognition in antibody-antigen complexes
Sundberg, E. J., & Mariuzza, R. A. (2002) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(02)61004-6 · Cited by 252 · cited 1×
“In this respect, Tie2 seems to interact with its angiopoietin ligands in a manner similar to the way antibodies bind antigen”
BackgroundLin, P., Polverini, P., Dewhirst, M., Shan, S., Rao, P. S., & Peters, K. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119740 · Cited by 252 · cited 1×
“Administration of soluble Tie2 ectodomain reduces vascular length density and tumor growth in vivo”
BackgroundDavis, S., Papadopoulos, N., Aldrich, T. H., Maisonpierre, P. C., Huang, T., Kovac, L., Xu, A., Leidich, R., Radziejewska, E., Rafique, A., et al. (2003) · Nature Structural Biology · doi:10.1038/nsb880 · Cited by 234
Crystal structure of a 30 kDa C-terminal fragment from the γ chain of human fibrinogen
Yee, V. C., Pratt, K. P., Côté, H. C., Trong, I. L., Chung, D. W., Davie, E. W., Stenkamp, R. E., & Teller, D. C. (1997) · Structure · doi:10.1016/s0969-2126(97)00171-8 · Cited by 211
Structural features of the reactions between antibodies and protein antigens
Braden, B. C., & Poljak, R. J. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.1.7821765 · Cited by 209 · cited 1×
“In this respect, Tie2 seems to interact with its angiopoietin ligands in a manner similar to the way antibodies bind antigen”
BackgroundA dimeric crystal structure for the N-terminal two domains of intercellular adhesion molecule-1
Casasnovas, J. M., Stehle, T., Liu, J.-H., Wang, J.-H., & Springer, T. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4134 · Cited by 203 · cited 1×
“For example, analogous to the division of the C set into C1 and C2 subsets, a subdivision of the I set into I1 and I2 has been suggested, depending on whether or not a D strand is presen”
BackgroundEph signaling: a structural view
Himanen, J.-P., & Nikolov, D. B. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)00005-x · Cited by 202 · cited 1×
“In this respect, the aniopoeitin-Tie2 system is similar to that of the Eph receptors and their ephrin ligands, which also form ligand-receptor clusters at the sites of cell-cell contac”
BackgroundSelf-citationFiedler, U., Krissl, T., Koidl, S., Weiss, C., Koblizek, T., Deutsch, U., Martiny-Baron, G., Marmé, D., & Augustin, H. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208550200 · Cited by 195 · cited 1×
“Domain-deletion analysis indicates that the Ig-EGF region of Tie2 mediates angiopoietin recognition and bindin”
BackgroundOligomerization and Multimerization Are Critical for Angiopoietin-1 to Bind and Phosphorylate Tie2
Kim, K.-T., Choi, H.-H., Steinmetz, M. O., Maco, B., Kammerer, R. A., Ahn, S. Y., Kim, H.-Z., Lee, G. M., & Koh, G. Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500292200 · Cited by 170 · cited 1×
“Indeed, all angiopoietins exist primarily as tetramers, hexamers and higher-order oligomers in solutio”
BackgroundFreigang, J., Proba, K., Leder, L., Diederichs, K., Sonderegger, P., & Welte, W. (2000) · Cell · doi:10.1016/s0092-8674(00)80852-1 · Cited by 170 · cited 1×
“It deviates from the canonical I1 topology because it lacks the C′ strand, a fact that has also been reported for other I-subset members, such as Axoni”
BackgroundThe angiopoietins and Tie2/Tek: adding to the complexity of cardiovascular development
Ward, N. L., & Dumont, D. (2002) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.2001.0288 · Cited by 166 · cited 1×
“The coiled-coil and the superclustering motifs are also required for signaling because they mediate ligand oligomerization, which is necessary for receptor activatio”
BackgroundPeters, K., Coogan, A., Berry, D., Marks, J., Iglehart, J., Kontos, C., Rao, P., Sankar, S., & Trogan, E. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.8 · Cited by 158
Zdanov, A., Li, Y., Bundle, D. R., Deng, S. J., MacKenzie, C. R., Narang, S. A., Young, N. M., & Cygler, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6423 · Cited by 153 · cited 1×
“Ig2 is structurally most similar to the Fv fragment of an antibody to a carbohydrat”
BackgroundPratt, K. P., Côté, H. C. F., Chung, D. W., Stenkamp, R. E., & Davie, E. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7176 · Cited by 150
Kairies, N., Beisel, H.-G., Fuentes-Prior, P., Tsuda, R., Muta, T., Iwanaga, S., Bode, W., Huber, R., & Kawabata, S.-I. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201523798 · Cited by 141 · cited 1×
“Notably, the ligand-binding sites in the fibrinogen domains of tachylectin 5A (ref”
BackgroundStructural insights into the antigenicity of myelin oligodendrocyte glycoprotein
Breithaupt, C., Schubart, A., Zander, H., Skerra, A., Huber, R., Linington, C., & Jacob, U. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133443100 · Cited by 136
Ziegler, S. F., Ta, B., Ja, S., Schooley, K., & Pr, B. (1993) · PubMed · Cited by 106
Barton, W. A., Tzvetkova‐Robev, D., & Nikolov, D. B. (2005) · Structure · doi:10.1016/j.str.2005.03.009 · Cited by 92 · cited 1×
“Domain-deletion analysis indicates that the Ig-EGF region of Tie2 mediates angiopoietin recognition and bindin”
BackgroundSelf-citationTie2 vascular endothelial receptor expression and function in hepatocellular carcinoma
Tanaka, S., Sugimachi, K., Yamashita, Y.-I., Ohga, T., Shirabe, K., Shimada, M., Wands, J. R., & Sugimachi, K. (2002) · Hepatology · doi:10.1053/jhep.2002.32535 · Cited by 90 · cited 1×
“Tie2 overexpression has been documented in breast, ovarian and hepatocellular tumors, as well as in glioblastoma”
BackgroundGetting Tie(2)d up in angiogenesis
Ramsauer, M., & D’Amore, P. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci17326 · Cited by 84 · cited 1×
“Tie receptors, comprised of Tie1 and Tie2, are type 1 transmembrane protein RTK”
BackgroundGetting Tie(2)d up in angiogenesis
Ramsauer, M., & D’Amore, P. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0217326 · Cited by 70
Hata, K., Udagawa, J., Fujiwaki, R., Nakayama, K., Otani, H., & Miyazaki, K. (2002) · Oncology · doi:10.1159/000065066 · Cited by 64 · cited 1×
“Tie2 overexpression has been documented in breast, ovarian and hepatocellular tumors, as well as in glioblastoma”
Background一次的フィブリン重合ポケット ペプチドGly‐Pro‐Arg‐Proと複合した30kDaのC端γ鎖断片の三次元構造
Pratt, K. P., Côté, H. C. F., Chung, D. W., Stenkamp, R. E., & Davie, E. W. (1997) · Proceedings of the National Academy of Sciences · Cited by 54
Evans, G., & Bricogne, G. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902005486 · Cited by 50 · cited 1×
“Subsequent calculations were performed using autoSHAR”
Ligand-binding sites in Ig-like domains of receptor tyrosine kinases
Wiesmann, C., Muller, Y. A., & de Vos, A. M. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000082 · Cited by 41 · cited 1×
“Tie2 Ig and EGF domains Many cell-surface signaling receptors contain Ig domains as ligand-recognition module”
BackgroundVascular development: molecular logic for defining arteries and veins
Sato, T. N. (2003) · Current Opinion in Hematology · doi:10.1097/00062752-200303000-00006 · Cited by 12
Cited by
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
Augustin, H. G., Young Koh, G., Thurston, G., & Alitalo, K. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2639 · Cited by 1,465
Fagiani, E., & Christofori, G. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.08.018 · Cited by 676
Design of protein-binding proteins from the target structure alone
Cao, L., Coventry, B., Goreshnik, I., Huang, B., Sheffler, W., Park, J. S., Jude, K. M., Marković, I., Kadam, R. U., Verschueren, K. H. G., et al. (2022) · Nature · doi:10.1038/s41586-022-04654-9 · Cited by 577
VEGF and angiopoietin signaling in tumor angiogenesis and metastasis
Saharinen, P., Eklund, L., Pulkki, K., Bono, P., & Alitalo, K. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.01.015 · Cited by 478
Metadata
- Authors
- Barton, W. A., Tzvetkova-Robev, D., Miranda, E. P., Kolev, M. V., Rajashankar, K. R., Himanen, J. P., & Nikolov, D. B.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Nikolov, Dimitar B
- Venue
- Nature Structural & Molecular Biology
- Published
- 2006-05-28
- Volume
- 13
- Issue
- 6
- Pages
- 524-532
- ISSN
- 1545-9985 (ISSN-L)
- 1545-9993
- OpenAlex
- W2100589229
- Cited by
- 134
- References
- 51
- Citations by year
- 2026: 9 · 2025: 2 · 2024: 4 · 2023: 3 · 2022: 3 · 2021: 11 · 2020: 4 · 2019: 8 · 2018: 4 · 2017: 9 · 2016: 6 · 2015: 8 · 2014: 9 · 2013: 12 · 2012: 7
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Structural & Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL077249)
- National Center for Research Resources (RR 15301, P41RR015301)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- Tie2 receptor, angiopoietin-2, receptor tyrosine kinase, ligand-binding domain, immunoglobulin domains, epidermal growth factor domain, receptor activation mechanism, angiogenesis, structure-guided mutagenesis
- MeSH terms
- Amino Acid Sequence, Calcium, Chromatography, Gel, Epidermal Growth Factor, Fibrinogen, Models, Molecular, Molecular Sequence Data, Protein Binding, Protein Conformation, Sequence Homology, Amino Acid, Crystallography, X-Ray, Angiopoietin-2, Receptor, TIE-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.